Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C784529-100 100 µg $511 
CISD1 Antibody - Anti-CISD1 mouse monoclonal antibody  immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CISD1.
CISD1 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CISD1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CISD1.
CISD1 Antibody - Flow cytometric Analysis of Jurkat cells, using anti-CISD1 antibody, (Red), compared to a nonspecific negative control antibody, (Blue).
CISD1 Antibody - Anti-CISD1 mouse monoclonal antibody  immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CISD1.
CISD1 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CISD1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CISD1.
CISD1 Antibody - Flow cytometric Analysis of Jurkat cells, using anti-CISD1 antibody, (Red), compared to a nonspecific negative control antibody, (Blue).
1 of 3
2 of 3
3 of 3

Monoclonal Mouse anti‑Human CISD1 Antibody (clone OTI2B3, Carrier‑free, IF, WB) LS‑C784529

Monoclonal Mouse anti‑Human CISD1 Antibody (clone OTI2B3, Carrier‑free, IF, WB) LS‑C784529

Antibody:
CISD1 Mouse anti-Human Monoclonal (Carrier-free) (OTI2B3) Antibody
Application:
IF, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Carrier-free
Other formats:
Price
Catalog Number
$511
LS-C784529-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
CISD1 Mouse anti-Human Monoclonal (Carrier-free) (OTI2B3) Antibody
Application:
IF, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Carrier-free
Other formats:

Specifications

Description
CISD1 antibody LS-C784529 is an unconjugated mouse monoclonal antibody to human CISD1. Validated for Flow, IF and WB.
Target
Human CISD1
Synonyms
CISD1 | CDGSH iron sulfur domain 1 | C10orf70 | MDS029 | ZCD1 | MitoNEET
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
OTI2B3
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free. Also available Unmodified.
Immunogen
Full length human recombinant protein of human CISD1 (NP_060934) produced in HEK293T cell.
Applications
  • Immunofluorescence
  • Western blot (1:200)
  • Flow Cytometry
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CISD1
Q9NZ45 NM_018464 NP_060934.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 6/25/2024